IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211,424,711 | +380.9% | 13,322,288 | +471.8% | 4.16% | +401.4% |
| Q2 2023 | $43,966,307 | -47.6% | 2,329,958 | -89.3% | 0.83% | -56.3% |
| Q1 2023 | $83,919,199 | -22.6% | 21,853,958 | 0.0% | 1.90% | -13.6% |
| Q4 2022 | $108,395,632 | +4.3% | 21,853,958 | +0.5% | 2.20% | -0.9% |
| Q3 2022 | $103,924,000 | +6.2% | 21,741,458 | 0.0% | 2.22% | -15.0% |
| Q2 2022 | $97,837,000 | -5.5% | 21,741,458 | 0.0% | 2.61% | +15.5% |
| Q1 2022 | $103,489,000 | -31.1% | 21,741,458 | +7.4% | 2.26% | -14.7% |
| Q4 2021 | $150,192,000 | +43.8% | 20,241,458 | +9.9% | 2.65% | +83.0% |
| Q3 2021 | $104,427,000 | -14.0% | 18,417,458 | 0.0% | 1.45% | -25.7% |
| Q2 2021 | $121,371,000 | -18.6% | 18,417,458 | 0.0% | 1.95% | -13.4% |
| Q1 2021 | $149,181,000 | +25.6% | 18,417,458 | 0.0% | 2.25% | +35.4% |
| Q4 2020 | $118,793,000 | +368.7% | 18,417,458 | +161.6% | 1.66% | +258.0% |
| Q3 2020 | $25,346,000 | +43.9% | 7,040,485 | +36.3% | 0.46% | -16.5% |
| Q1 2020 | $17,617,000 | – | 5,166,303 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |